1887

Abstract

The human immunodeficiency virus type 1 (HIV-1) gene product Pr55 self-assembles to form virus-like particles when expressed in cells using recombinant baculoviruses. The particles resemble immature HIV and are released from the infected cell into the culture medium. Using this system we have progressively truncated the open reading frame from the C terminus and examined each deleted gag protein for its particle-producing capability. We show that deletion of Pr6 and deletions that progressively remove the distal region of the Pr7 domain, including one Cys-His box thought to function as an RNA capture signal, do not affect particle formation. However deletion of two Cys-His boxes causes production of slightly larger particles with altered sedimentation properties. Sequence-specific North-Western assays using an RNA probe representative of the HIV-1 packaging signal revealed specific RNA binding by all mutants that maintained both Cys-His boxes. However, deletion of one Cys-His box reduced RNA binding substantially and loss of two Cys-His boxes abolished binding entirely. We conclude that HIV-1 gag particle formation does not require viral RNA encapsidation, but that it may act as a cofactor in the condensation of the immature core. Further deletion of gag sequences upstream of the Cys-His boxes led to the abolition of particle-forming ability, and we show that one boundary of the gag sequence necessary for particle formation lies within eight amino acids spanning one of the known protease cleavage sites at the C terminus of Pr24.

Erratum

An erratum has been published for this content:
Corrigendum
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-73-12-3079
1992-12-01
2022-01-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/73/12/JV0730123079.html?itemId=/content/journal/jgv/10.1099/0022-1317-73-12-3079&mimeType=html&fmt=ahah

References

  1. Clavel F., Orenstein J. M. 1990; A mutant of human immunodeficiency virus with reduced RNA packaging and abnormal particle morphology. Journal of Virology 64:5230–5234
    [Google Scholar]
  2. Delchambre M., Gheysen D., Thines D., Thiriart C., Jacobs E., Verdin E., Horth M., Burny A., Bex F. 1989; The Gag precursor of simian immunodeficiency virus assembles into virus-like particles. EMBO Journal 8:2653–2660
    [Google Scholar]
  3. Felsenstein K. M., Goff S. P. 1988; Expression of the Gag-Pol fusion protein of Moloney murine leukemia virus without Gag protein does not induce virion formation or proteolytic processing. Journal of Virology 62:2179–2182
    [Google Scholar]
  4. Gelderblom H. R. 1991; Assembly and morphology of HIV: potential effect of structure on viral function (editorial). AIDS 5:617–637
    [Google Scholar]
  5. Gheysen D., Jacobs E., De-Foresta F., Thiriart C., Francotte M., Thines D., De-Wilde M. 1989; Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells. Cell 59:103–112
    [Google Scholar]
  6. Gorelick R. J., Nigida S. M. Jr, Bess J. W. Jr, Arthur L. O., Henderson L. E., Rein A. 1990; Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA. Journal of Virology 64:3207–3211
    [Google Scholar]
  7. Gottlinger H. G., Dorfman T., Sodroski J. G., Haseltine W. A. 1991; Effect of mutations affecting the Pr6 Gag protein on human immunodeficiency virus particle release. Proceedings of the National Academy of Sciences, U.S.A. 88:3195–3199
    [Google Scholar]
  8. Haffar O. K., Smithgall M. D., Moran P. A., Travis B. M., Zarling J. M., Hu S. L. 1991; HIV-specific humoral and cellular immunity in rabbits vaccinated with recombinant human immunodeficiency virus Gag-Env particles. Virology 183:487–495
    [Google Scholar]
  9. Hoshikawa N., Kojima A., Yasuda A., Takayashiki E., Musako S., Chiba J., Sata T., Kurata T. 1991; Role of the gag and pol genes of human immunodeficiency virus in the morphogenesis and maturation of retrovirus-like particles expressed by recombinant vaccinia virus: an ultrastructural study. Journal of General Virology 72:2509–2517
    [Google Scholar]
  10. Hu S. L., Travis B. M., Garrigues J., Zarling J. M., Sridhar P., Dykers T., Eichberg J. W., Alpers C. 1990; Processing, assembly, and immunogenicity of human immunodeficiency virus core antigens expressed by recombinant vaccinia virus. Virology 179:321–329
    [Google Scholar]
  11. Jacks T., Power M. D., Masiarz F. R., Luciw P. A., Barr P. J., Varmus H. E. 1988; Characterization of ribosomal frameshifting in HIV-1 Gag-Pol expression. Nature, London 331:280–283
    [Google Scholar]
  12. Karacostas V., Nagashima K., Gonda M. A., Moss B. 1989; Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector. Proceedings of the National Academy of Sciences, U.S.A. 86:8964–8967
    [Google Scholar]
  13. Katoh I., Yoshinaka Y. 1990; RNA-binding activities of bovine leukemia virus gag proteins. Abstracts of the VIIIth International Conference of Virology. Berlin, 26 to 31 August, 1990 Abstract W45–005, p 80
    [Google Scholar]
  14. Kieny M. P. 1990; Structure and regulation of the human AIDS virus. Journal of Acquired Immune Deficiency Syndromes 3:395–402
    [Google Scholar]
  15. Kitts P., Ayres M., Possee R. 1991; Linearisation of baculovirus DNA improves the selection of recombinants. Nucleic Acids Research 18:5667–5672
    [Google Scholar]
  16. Kunkel T. A. 1985; Rapid and efficient site-specific mutagenesis without phenotypic selection. Proceedings of the National Academy of Sciences, U.S.A. 82:488–492
    [Google Scholar]
  17. Lever A., Gottlinger H., Haseltine W., Sodroski S. 1989; Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions. Journal of Virology 63:4085–4087
    [Google Scholar]
  18. Livingstone C., Jones I. M. 1989; Baculovirus expression vectors with single-strand capability. Nucleic Acids Research 17:2366
    [Google Scholar]
  19. Loeber G., Stenger J. E., Ray S., Parsons R. E., Anderson M. E., Tegtmeyer P. 1991; The zinc finger region of simian virus 40 large T antigen is needed for hexamer assembly and origin melting. Journal of Virology 65:3167–3174
    [Google Scholar]
  20. Luban J., Goff S. P. 1991; Binding of human immunodeficiency virus type 1 (HIV-1) RNA to recombinant HIV-1 Gag polyprotein. Journal of Virology 65:3203–3212
    [Google Scholar]
  21. Luftig R., Ikuta K., Bu M., Calkins P. 1990; Terminal stages of retroviral morphogenesis. In Retroviral Proteases: Maturation and Morphogenesis pp 141–148 Edited by Pearl L. H. London: Macmillan;
    [Google Scholar]
  22. Luo L., Li Y., Kang Y. 1990; Expression of Gag precursor protein and secretion of virus-like particles of HIV-2 from recombinant baculovirus infected insect cells. Virology 179:874–880
    [Google Scholar]
  23. Mergener K., Facke M., Welker R., Brinkman V., Gelderblom H. R., Krausslich H. G. 1992; Analysis of HIV particle formation using transient expression of subviral constructs in mammalian cells. Virology 186:25–39
    [Google Scholar]
  24. Mervis R. J., Ahmad N., Lillehoj E. P., Raum M. G., Salazar F. H., Chan H. W., Venkatesan S. 1988; The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of post-translational modifications, and evidence for alternative Gag precursors. Journal of Virology 62:3993–4002
    [Google Scholar]
  25. Morikawa S., Booth T. F., Bishop D. H. 1991; Analyses of the requirements for the synthesis of virus-like particles by feline immunodeficiency virus Gag using baculovirus vectors. Virology 183:288–297
    [Google Scholar]
  26. Overton H. A., Fujii Y., Price I. R., Jones I. M. 1989; The protease and gag gene products of the human immunodeficiency virus: authentic cleavage and post-translational modification in an insect cell expression system. Virology 170:107–116
    [Google Scholar]
  27. Rasmussen L., Battles J. K., Ennis W. H., Nagashima K., Gonda M. A. 1990; Characterization of virus-like particles produced by a recombinant baculovirus containing the gag gene of the bovine immunodeficiency-like virus. Virology 178:435–451
    [Google Scholar]
  28. Royer M., Cerutti M., Gay B., Hong S. S., Devauchelle G., Boulanger P. 1991; Functional domains of HIV-1 Gag-polyprotein expressed in baculovirus-infected insect cells. Virology 184:417–422
    [Google Scholar]
  29. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning: A Laboratory Manual 2nd edn New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  30. Shioda T., Shibuta H. 1990; Production of human immunodeficiency virus (HIV)-like particles from cells infected with recombinant vaccinia viruses carrying the gag gene of HIV. Virology 175:139–148
    [Google Scholar]
  31. Smith A. J., Cho M. I., Hammarskjold M. L., Rekosh D. 1990; Human immunodeficiency virus type 1 Pr55gag and Prl60Gag-Pol expressed from a simian virus 40 late replacement vector are efficiently processed and assembled into virus like particles. Journal of Virology 64:2743–2750
    [Google Scholar]
  32. Summers M. D., Smith G. E. 1987 A Manual of Methods for Baculovirus Vectors and Insect Cell Culture Procedures Texas Agricultural Experimental Research Station; Bulletin no 1555
    [Google Scholar]
  33. Veronese F. D., Rahman R., Copeland T. D., Oroszlan S., Gallo R. C., Sarngadharan M. G. 1987; Immunological and chemical analysis of Pr6, the carboxy terminal fragment of HIV Prl5. AIDS Research and Human Retroviruses 3:253–264
    [Google Scholar]
  34. Veronese F. D., Copeland T. D., Oroszlan S., Gallo R. C., Sarngadharan M. G. 1988; Biochemical and immunological analysis of human immunodeficiency virus gag gene products Prl7 and Pr24. Journal of Virology 62:795–801
    [Google Scholar]
  35. Wills J. W., Craven R. C. 1991; Form, function, and use of retroviral Gag proteins (editorial). AIDS 5:639–654
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-73-12-3079
Loading
/content/journal/jgv/10.1099/0022-1317-73-12-3079
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error